What is OS Therapies's net income?

OS Therapies (OSTX) reported net income of -$10.4M in Q1 2026.

How has OS Therapies's net income changed year-over-year?

OS Therapies's net income decreased by 168.2% year-over-year, from -$3.88M to -$10.4M.

Over 2 years (2023 to 2025), OS Therapies's net income has grown at a 90.6% compound annual growth rate (CAGR), from -$7.92M to -$28.75M.

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is OS Therapies's net income?: OS Therapies (OSTX) reported net income of -$10.4M in Q1 2026.
How has OS Therapies's net income changed year-over-year?: OS Therapies's net income decreased by 168.2% year-over-year, from -$3.88M to -$10.4M.
What is the long-term trend for OS Therapies's net income?: Over 2 years (2023 to 2025), OS Therapies's net income has grown at a 90.6% compound annual growth rate (CAGR), from -$7.92M to -$28.75M.